Entrada Therapeutics is a biotechnology company that is focused on developing therapies for diseases that are difficult to treat. The company's proprietary platform technology allows for the delivery of large molecules, such as proteins and nucleic acids, into cells and tissues that were previously inaccessible. This technology has the potential to transform the treatment of a wide range of diseases, including genetic disorders, cancer, and autoimmune diseases. Entrada Therapeutics was founded in 2016 and is headquartered in Waltham, Massachusetts.